SCHEMBL31002980

SCHEMBL31002980

[2H]C([2H])(O)C1(Nc2nc(Cl)nc3c2[S@+]([O-])CC3)CCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31622416 1.00 — —
SCHEMBL30639342 0.90 LATS1 (0.32) —
SCHEMBL30639341 0.90 LATS1 (0.32) —
SCHEMBL31571836 0.90 LATS1 (0.32) —
SCHEMBL14734142 0.90 LATS1 (0.32) —
SCHEMBL29576569 0.88 LATS1 (0.32) —
SCHEMBL31491332 0.85 — —
SCHEMBL30678865 0.84 LATS1 (0.32) —
SCHEMBL30678848 0.84 LATS1 (0.32) —
SCHEMBL30678840 0.84 LATS1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025124557-A1 DEUTERATED HETEROCYCLIC COMPOUND ACTING AS PDE4B INHIBITOR AND USE THEREOF 武汉人福创新药物研发中心有限公司 2025-06-19 — — WO disclosed
CN-120157682-A Deuterated heterocyclic compounds as PDE4B inhibitors and uses thereof 武汉人福创新药物研发中心有限公司 2025-06-17 — — CN disclosed
CN-118146236-A Substituted dihydrothienoazaheteroaryl derivatives, methods of preparation and use of prodrugs thereof 上海翊石医药科技有限公司 2024-06-07 — — CN disclosed
Send feedback